<DOC>
	<DOC>NCT00770861</DOC>
	<brief_summary>This study will evaluate the efficacy and safety of nebivolol monotherapy in Hispanic patients with stage 1 or stage 2 hypertension</brief_summary>
	<brief_title>A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Male and female outpatients 18 to 80 years of age, selfidentified as Hispanic or Latino ethnicity Females must be postmenopausal, or not pregnant and using an approved contraceptive regimen Meet criteria for stage I or II hypertension Currently not treated, or being treated with no more than two antihypertensive medications Secondary hypertension Are taking three or more antihypertensive agents Have uncontrolled or poorly controlled diabetes mellitus type I or type II Evidence of other concurrent disease or conditions that might interfere with the conduct of the study Participation in any investigational study within 30 days of Screening (Visit 1). Have a history of hypersensitivity to nebivolol or other βblockers, or any contraindication to βblocker use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>nebivolol</keyword>
	<keyword>Bystolic ™</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Hispanic</keyword>
	<keyword>Hypertension in Hispanic patients</keyword>
</DOC>